Recombinant human anti–transforming growth factor β1 antibody therapy in systemic sclerosis: A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192 (Q61646585)
scientific article published on 01 January 2007
Language:
(P31) (Q13442814)
(P50) (Q40159573)
(Q55686130)
(Q19859634)
(P304) 323-333
(P433) 1
(P478) 56
(P577) Monday, January 1, 2007
(P921) (Q327657)
(Q269829)
(Q5452194)
(Q6934595)
(P1433) (Q23929027)
(P1476) "Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192" (language: en)
(P2093) Dinesh Khanna
Nancy Silliman
James Streisand
John Powell
John Coppock
Frank van den Hoogen
Joanna Haas
Stephen Ledbetter
Christopher P Denton
Peter A Merkel
Daniel E Furst
Vivien M Hsu
Anita Akesson
Maureen D Mayes
Joseph H Korn
Carol M Black
James R Seibold
Cat-192 Study Group
Scleroderma Clinical Trials Consortium
other details
description scientific article published on 01 January 2007

External Links